New York
Margaret represents companies and individuals in high-stakes litigation in federal and state courts nationwide. She has extensive experience in all stages of litigation, from pre-suit demands through the conclusion of the appellate process.
Washington, D.C.
Esther also regularly advises on diversity and inclusion initiatives, such as pay equity studies, intentional recruiting and lawful affirmative action plans and goals.
In addition to her litigation practice, she counsels clients on all areas of federal, state and local employment law, including executive terminations; severance agreements; workforce reductions; and compliance with federal and state obligations such as the WARN Act and the Older Workers Benefit Protection Act.
She also provides advice regarding the proper validation of employment selection procedures to ensure compliance with Title VII and other applicable employment laws. Esther has specific expertise in testing validation and she routinely reviews validation and adverse impact studies to provide clients with strategic advice regarding the defensibility of selection devices, including algorithmic decision-making tools used to assess applicants and employees.
She previously served as the principal deputy chief of the Employment Litigation Section within the Civil Rights Division of the DOJ.
New York
She supports clients in the energy and infrastructure spaces through development, financing, construction and operation of their projects, often working to develop novel and bespoke legal solutions.
Wheeling, W.V. (GOIC)
Wheeling, W.V. (GOIC)
Daryl manages a team of 40+ tech-savvy attorneys, 100+ contract attorneys, analysts that handle project management, perform big data analysis and statistical modeling, and technologists that build bots, scripts and tools that increase quality and reduce human effort. Daryl’s team designs processes, workflows, templates and document automation used by dedicated project managers to deliver project plans and enable data driven budgeting and decision-making. As an early adopter of artificial intelligence and machine learning, Daryl’s team uses technology to augment due diligence and drafting tasks, TAR and continuous active learning for litigation projects, and advanced tools for concept and sentiment analysis.
Daryl’s mission is straightforward: enhance accuracy, speed and security of scalable legal work, generate insights specific to the engagement and reduce client cost.
Daryl helps administer Orrick's Legal Technology Innovation Initiative.
Prior to joining Orrick, Daryl was a Partner at LeClairRyan in Virginia.
Düsseldorf
She advises start-ups from their incorporation through their first financing rounds into the growth phase, as well as on internationalization projects. Martha works with venture capital, as well as corporate venture capital investors on start-up financing projects.
Prior to joining Orrick, Martha worked as a trainee lawyer for another international law firm and United Nations Women in Bonn.
Washington, D.C.
Washington, D.C.
Sonora's practice includes a diverse range of complex litigation, regulatory enforcement, and government-initiated investigation matters. She also maintains an active pro bono practice.
Sonora received her J.D. from the Howard Law School in Washington, D.C. While in law school, she participated in the Howard Criminal Justice Clinic where she represented indigent individuals charged with misdemeanors in Washington, D.C. Superior Court. Sonora was also a student attorney in the Howard Civil Rights Clinic where she contributed to an amicus brief in the landmark case Dobbs v. Jackson Women’s Health Organization.
Washington, D.C.
He currently is national coordinating counsel for a major oil company in connection with its climate change litigation. He previously served as co-lead counsel to a major international pharmaceutical manufacturer in the defense of nationwide litigation challenging industry pricing practices.
Rob’s experience includes extensive work in antitrust and False Claims Act cases, claims alleging fraud, and agency enforcement actions. His pharmaceutical industry activities include service as outside counsel to and Corporate Secretary of the Pharmaceutical Security Institute, Inc., the industry’s not-for-profit trade organization dedicated to the fight against pharmaceutical counterfeiting.
He is Managing Editor of The World in U.S. Courts, Orrick’s quarterly review of court decisions addressing personal jurisdiction over non-U.S. parties and the extraterritorial application of U.S. law to global business and cross-border activities.
Rob also served two terms on the District of Columbia Bar’s Pro Bono standing committee. Before joining Orrick, he was a partner in Hughes Hubbard & Reed LLP and Clifford & Warnke, in Washington, D.C.
New York
Tyler has represented clients in the federal district courts, before the United States Court of Appeals for the Federal Circuit and at the United States Patent and Trademark Office in IPR and CBM matters. He has experience in matters involving a wide range of technologies, including software, consumer electronics and biotechnology.
Santa Monica
Caroline advises emerging and high growth companies throughout their lifecycle, as well as venture funds and other investors, across a variety of industries. Her practice focuses on venture financings and corporate governance matters, and the general day-to-day legal needs of startups. She has also counseled companies on M&A, securities and technology transactions matters.
Caroline is a frequent speaker on fundraising essentials for emerging growth companies and sits on the board of the Los Angeles Venture Association.
Prior to joining Orrick, Caroline was a Partner and Co-Chair of the Venture Capital & Emerging Growth Practice at Stubbs Alderton & Markiles.
San Francisco
San Francisco
New York
With a Ph.D. in biology from MIT and the Whitehead Institute, where she was a NSF fellow, Irena represents plaintiffs and defendants in their most complex pharmaceutical and biotech patent cases. Over the last 20 years, pharmaceutical and biotechnology innovators have relied on Irena again and again for cases involving small molecules, biologics, recombinant DNA technology, gene therapy, gene editing, manufacturing processes, formulations and drug-eluting medical devices, including numerous multi-billion dollar cases involving many of the world’s best-selling drugs.
Irena has significant experience in litigation under the Hatch-Waxman Act (ANDA and 505(b)(2) actions) and the Biologics Price Competition and Innovation Act (BPCIA), as well as inter partes review (IPR) proceedings, license disputes and matters with parallel ex-U.S. litigation and proceedings in foreign patent offices. Irena also helps life sciences companies and organizations develop the law in the most important cases for the biopharma industry. She has been principal counsel on numerous amicus briefs to the United States Supreme Court and the Federal Circuit in key biopharma cases.
For plaintiffs, Irena has successfully defended generic challenges to patents protecting blockbuster medical therapies, including multi-billion dollar cancer, antiviral, diabetes and anti-psychotic drugs, including recently obtaining attorneys’ fees in a hard-fought ANDA action. She also represents innovators in biosimilar litigation from its outset, including in some of the first cases under the BPCIA involving antibodies. Irena also represents clients in innovator vs innovator disputes. For defendants, she defeated a $530 million claim of patent infringement of a competitor’s biotech patent, obtaining dismissal of all claims and discovery sanctions against the patent owner. In another high-stakes case, she obtained summary judgment of noninfringement and exclusion of plaintiff’s experts under Daubert as well as a full award of attorneys’ fees. A registered patent attorney, Irena also handles inter partes review (IPR) proceedings. For patent owners, she has obtained denial of IPR for patents protecting blockbuster drugs and has leveraged IPR for defendants to obtain freedom to operate.
Irena also coordinates U.S. proceedings with parallel ex-U.S. litigation and proceedings in foreign patent offices, recently obtaining freedom to operate for a biotech innovator’s gene therapy. She provides strategic counseling in biologics and pharmaceuticals and advises clients on their IP portfolios and transactions. Irena also represents clients in high-stakes license disputes involving biotech patents, and, in a dispute concerning the use of a recombinant protein as an enzyme replacement therapy, obtained one of the largest settlement awards over the life of the contract.
Chambers USA has recognized Irena as a leading lawyer in intellectual property, where clients have described her as “excellent,” “knowledgeable, aggressive,” “knows the science forward and backward” and “an incredibly smart lawyer.” Benchmark Litigation named her one of the “Top 250 Women in Litigation” for the last eight years and a litigation star in intellectual property. Irena was also named to the Crain’s New York Business list of “Notable Women in Law.” She is also recognized as a leading lawyer by Legal 500. Irena writes and lectures widely on biopharma patent issues and biosimilar litigation. Irena also is frequently quoted on patent-related issues, including in the Washington Post, Financial Times, Nature Biotechnology, Bloomberg and Pink Sheet.
Seattle
Lauren represents clients in high-stakes appeals, with a focus on patent litigation. Lauren also joins trial teams as embedded appellate counsel to guide the legal strategy with an eye toward appeal and draft important briefs. She has argued in the Federal Circuit on behalf of a leading video-game developer, where she secured affirmance of the PTAB's decision striking down every claim of a competitor's patent, and in the Ninth Circuit, where she won relief from removal for a client seeking asylum. She has co-authored dozens of appellate briefs, as well as briefs in the U.S. Supreme Court at both the certiorari and merits stages. Lauren also has an active pro bono practice focused on immigration matters and civil rights.
Before joining Orrick, Lauren served as a law clerk to Judge Susan P. Graber of the U.S. Court of Appeals for the Ninth Circuit and Judge John R. Blakey of the U.S. District Court for the Northern District of Illinois. Lauren graduated summa cum laude from the University of Wisconsin Law School, where she received the Salmon Dalberg Award for outstanding member of the graduating class and was a Managing Editor for the Wisconsin Law Review. Before law school, Lauren worked for a major software company in the healthcare industry.